Loading: 100%
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reasons:
- It is not known how cost items are reported in the original P&L
- Not all line items from the original statement have been associated with a standardised figure (16 items missing)
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15FY '16
Net revenues
1
2
2
2
3
5
Cost of sales (inclusive of depreciation and amortization of $1,054 and $1,406, respectively)
1
1
1
1
1
2
Gross Profit
1
1
1
1
1
3
Research and development
0
0
0
0
0
0
Selling, general and administrative
1
1
1
1
1
2
Stock based compensation
0
0
0
0
0
1
Depreciation and amortization
0
0
0
0
0
0
Total operating expenses
1
2
1
1
1
2
Income from operations
-1
0
-1
0
0
0
Interest income
0
0
0
0
0
0
Interest expense
0
0
0
0
0
0
Gain on settlement - Wellington
0
0
0
0
0
0
Total other income
0
0
0
0
0
0
Income before provision for income taxes
-1
0
0
0
0
0
Benefit for income taxes - deferred
0
0
0
0
0
1
Net income
-1
0
-1
0
0
1
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Jul 15, 2014 n/a
calculated values,
restated on Jul 14, 2015 n/a
calculated values,
restated on Jul 13, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Balance SheetBS data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (31 items missing)
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash and cash equivalents
0
0
0
0
0
1
Accounts receivable, net of allowance for doubtful accounts of $25,000 for each period
0
0
0
0
1
1
Inventories
0
0
0
0
0
0
Prepaid expenses and other current assets
0
0
0
0
0
0
Restricted cash
0
0
0
0
0
0
Deferred tax asset
0
0
0
0
0
0
Total current assets
1
1
1
1
1
3
Property and equipment, net of accumulated depreciation of $77,690 and $74,070, respectively
0
0
0
0
0
0
Inventories - long-term portion
0
0
0
0
0
0
Secured convertible note receivable, including interest of $20,900 for 2014
0
0
0
0
0
0
Advances to related parties
0
0
0
0
0
0
Net Carrying Amount
0
0
0
0
0
0
Other assets
0
0
0
0
0
0
Deferred tax asset
0
0
0
0
0
0
Total other assets
0
0
0
0
0
1
Total assets
1
1
1
1
1
3
Liabilities and owners' equity
Note payable - bank
0 172000
0 160000
0 147990
0 136990
0 121966
0 96966
Accounts payable
0 184122
0 148832
0 186373
0 208248
0 329291
0 276171
Note payable - other
0 13900
0 0
0 0
0 0
0 0
0 0
Accrued expenses and other current liabilities
0 56457
0 385935
0 385845
0 312901
0 221106
0 331231
Customer deposits
0 0
0 21023
0 0
0 24770
0 99102
0 108342
Due to shareholder
0 0
0 0
0 0
0 160006
0 223849
0 246696
Total current liabilities
0 426479
1 715790
1 720208
1 842915
1 995314
1 1059406
Total liabilities
0 426479
1 715790
1 720208
1 842915
1 995314
1 1059406
Preferred stock, $.01 par value; 5,000,000 shares authorized, no shares issued and outstanding
0 0
0 0
0 0
0 0
0 0
0 0
Common stock, $0.0005 par value; 150,000,000 authorized, 67,008,502 and 64,939,537 shares issued and outstanding at March 31, 2016 and March 31, 2015, respectively
0 28470
0 28470
0 29970
0 32470
0 32470
0 33504
Additional paid-in capital
32 32173097
32 32173097
32 32275594
32 32298094
32 32298094
33 33195759
Accumulated deficit
-32 -31557545
-32 -31580907
-32 -32118037
-32 -32343251
-32 -31984461
-31 -30866123
Total stockholders' equity
1 644022
1 620660
0 187527
0 -12687
0 346103
2 2363140
Total liabilities and stockholders' equity
1 1070501
1 1336450
1 907735
1 830228
1 1341417
3 3422546
Remarks restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Jul 14, 2015 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (35 items missing)
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15FY '16
Net income
-1
0
-1
0
0
1
Stock based compensation
0
0
0
0
0
1
Depreciation and amortization
0
0
0
0
0
0
Bad debt
0
0
0
0
0
0
Interest Receivable
0
0
0
0
0
0
Write-off of inventories
0
0
0
0
0
0
Write-off intangible asset
0
0
0
0
0
0
Gain on sale of equipment
0
0
0
0
0
0
Bad debt recovery
0
0
0
0
0
0
Forgiveness of note receivable - Wellington
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
-1
Accounts receivable
0
0
0
0
0
0
Inventories
0
0
0
0
0
0
Prepaid expenses and other current assets
0
0
0
0
0
0
Other assets
0
0
0
0
0
0
Accounts payable
0
0
0
0
0
0
Customer deposit
0
0
0
0
0
0
Accrued expenses and other current liabilities
0
0
0
0
0
0
Due to shareholder
0
0
0
0
0
0
Net cash provided by operating activities
-1
0
0
0
0
1
Repayment from related party
0
0
0
0
0
0
Repayment from secured convertible debt
0
0
0
0
0
0
Proceeds from sale of equipment
0
0
0
0
0
0
Investment in Angiodroid
0
0
0
0
0
0
Purchase of equipment
0
0
0
0
0
0
Restricted cash
0
0
0
0
0
0
Exercise of options
0
0
0
0
0
0
Net cash used in investing activities
0
0
0
0
0
0
Repayments on note payable - Bank
0
0
0
0
0
0
Repayments on note payable - Other
0
0
0
0
0
0
Sale of common stock
0
0
0
0
0
0
Net cash provided by (used) in Financing Activities
0
0
0
0
0
0
Net increase in cash and cash equivalents
-1
0
0
0
0
1
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,